Literature DB >> 24366415

Residual breast tissue after mastectomy: how often and where is it located?

M Griepsma1, D B W de Roy van Zuidewijn, A J K Grond, S Siesling, H Groen, G H de Bock.   

Abstract

BACKGROUND: Residual breast tissue after a mastectomy can lead to a (second) primary breast cancer. The development of breast cancer after prophylactic mastectomy and the finding of normal breast tissue around a local recurrence support this assumption. The aim of the present study was to investigate the prevalence and localization of residual breast tissue after a mastectomy.
METHODS: A series of 206 women who underwent a mastectomy between January 2008 and August 2009 in 11 hospitals were enrolled onto this study after written informed consent was obtained. From each mastectomy specimen, a total of 36 samples were obtained from the superficial dissection plane at predetermined locations. The biopsy samples were analyzed for the presence of benign breast tissue in the inked superficial area. Differences in percentage of positive samples were analyzed by generalized estimating equations to account for their interdependence.
RESULTS: A total of 7,374 biopsy samples from 206 breast specimens of 206 patients were included in the analysis. In 76.2 % of the specimens (n = 157), one or more positive biopsy samples were found. The positive findings were found diffusely across the superficial dissection surface of the specimen with a significant predilection for the lower outer quadrant and the middle circle of the superficial dissection plane.
CONCLUSIONS: After a mastectomy, there is a high probability of residual breast tissue. This tissue is predominantly located in the middle circle of the superficial dissection plane and in the lower outer quadrant. Surgeons should be aware of these locations so they may remove as much of the benign breast tissue as possible.

Entities:  

Mesh:

Year:  2013        PMID: 24366415     DOI: 10.1245/s10434-013-3383-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

Review 1.  Oncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomy.

Authors:  Victorien M T van Verschuer; Marike C Maijers; Carolien H M van Deurzen; Linetta B Koppert
Journal:  Gland Surg       Date:  2015-12

2.  Breast magnetic resonance imaging: are those who need it getting it?

Authors:  S Tan; J David; L Lalonde; M El Khoury; M Labelle; R Younan; E Patocskai; J Richard; I Trop
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

3.  Identifying the dissection plane for mastectomy-description and visualization of our technique.

Authors:  Camilla Bille; Farima Dalaei; Jørn Bo Thomsen
Journal:  Gland Surg       Date:  2019-10

4.  The PreQ-20 TRIAL: A prospective cohort study of the oncologic safety, quality of life and cosmetic outcomes of patients undergoing prepectoral breast reconstruction.

Authors:  Benigno Acea-Nebril; Alejandra García-Novoa; Lourdes García Jiménez
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

5.  Location and Frequency of Residual Breast Tissue after Mastectomy.

Authors:  Ibrahim Ustun; Kemal Beksac; Olcay Kandemir; Ugur Berberoglu
Journal:  Breast Care (Basel)       Date:  2019-03-14       Impact factor: 2.860

Review 6.  ESSM Position Statement "Sexual Wellbeing After Gender Affirming Surgery".

Authors:  Müjde Özer; Sahaand Poor Toulabi; Alessandra D Fisher; Guy T'Sjoen; Marlon E Buncamper; Stan Monstrey; Marta R Bizic; Miroslav Djordjevic; Marco Falcone; Nim A Christopher; Daniel Simon; Luis Capitán; Joz Motmans
Journal:  Sex Med       Date:  2021-12-28       Impact factor: 2.491

Review 7.  Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?

Authors:  Fabian Riedel; André Hennigs; Sarah Hug; Benedikt Schaefgen; Christof Sohn; Florian Schuetz; Michael Golatta; Jörg Heil
Journal:  Breast Care (Basel)       Date:  2017-12-12       Impact factor: 2.860

8.  From modified radical mastectomy to infra-radical mastectomy: a phase I study for surgical de-escalation focusing on pathological analyses.

Authors:  Veronique Jossa; Fabrice Olivier; Eric Lifrange; André Crevecoeur; Audrey Courtois; Michel Coibion; Guy Jerusalem
Journal:  Gland Surg       Date:  2021-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.